PMID- 20384472
OWN - NLM
STAT- MEDLINE
DCOM- 20100812
LR  - 20161125
IS  - 1748-295X (Electronic)
IS  - 1748-2941 (Linking)
VI  - 12
IP  - 2
DP  - 2010 Jun
TI  - Bivalirudin during percutaneous coronary interventions in patients with ST 
      segment elevation myocardial infarction.
PG  - 75-6
LID - 10.3109/17482941003732741 [doi]
AB  - Bivalirudin is a direct thrombin inhibitor that seems to be a promising 
      anticoagulation treatment in patient with ST elevation myocardial infarction 
      (STEMI) treated with primary percutaneous coronary intervention (PCI). We discuss 
      several issues that were raised from the use of Bivalirudin during primary PCI.
FAU - Koutouzis, Michael
AU  - Koutouzis M
FAU - Albertsson, Per
AU  - Albertsson P
LA  - eng
PT  - Letter
PL  - England
TA  - Acute Card Care
JT  - Acute cardiac care
JID - 101276603
RN  - 0 (Anticoagulants)
RN  - 0 (Hirudins)
RN  - 0 (Peptide Fragments)
RN  - 0 (Recombinant Proteins)
RN  - TN9BEX005G (bivalirudin)
SB  - IM
MH  - *Angioplasty, Balloon, Coronary
MH  - Anticoagulants/*therapeutic use
MH  - Hirudins
MH  - Humans
MH  - Myocardial Infarction/diagnosis/mortality/*therapy
MH  - Peptide Fragments/*therapeutic use
MH  - Recombinant Proteins/therapeutic use
MH  - Reproducibility of Results
MH  - Research Design
EDAT- 2010/04/14 06:00
MHDA- 2010/08/13 06:00
CRDT- 2010/04/14 06:00
PHST- 2010/04/14 06:00 [entrez]
PHST- 2010/04/14 06:00 [pubmed]
PHST- 2010/08/13 06:00 [medline]
AID - 10.3109/17482941003732741 [doi]
PST - ppublish
SO  - Acute Card Care. 2010 Jun;12(2):75-6. doi: 10.3109/17482941003732741.